Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen (Q46703423)

24 December 2017

title

Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen (English)

1 reference

24 December 2017

1 reference

Edison L Sampaio

1

1 reference

24 December 2017

Paula G Pinheiro-Machado

2

1 reference

24 December 2017

Riberto Garcia

3

1 reference

24 December 2017

Claudia R Felipe

4

1 reference

24 December 2017

Sung I Park

5

1 reference

24 December 2017

Dulce E Casarini

6

1 reference

24 December 2017

Silvia Moreira

7

1 reference

24 December 2017

Marcello F Franco

8

1 reference

24 December 2017

Helio Tedesco-Silva

9

1 reference

24 December 2017

Jose O Medina-Pestana

10

1 reference

24 December 2017

publication date

1 March 2008

1 reference

24 December 2017

published in

Clinical Transplantation

1 reference

24 December 2017

volume

22

1 reference

24 December 2017

page(s)

141-149

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

The effects of lipid-lowering agents on acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Determination of sirolimus blood concentration using high-performance liquid chromatography with ultraviolet detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Organization of a high-volume kidney transplant program--the "assembly line" approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Delayed graft function: risk factors and implications for renal allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Cyclosporine bioavailability of Neoral and Sandimmune in white and black de novo renal transplant recipients. Neoral Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Mycophenolic acid 12-h trough level monitoring in renal transplantation: association with acute rejection and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Post-transplantation proteinuria and sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Enhancement of human platelet aggregation and secretion induced by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2007.00756.X

10.1111/J.1399-0012.2007.00756.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18339132

1 reference

24 December 2017